New Test Helps Determine Risk of Deadly Disease
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Diagnostic Technologies, Disease States |
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 2, 2023 | Prostate |
Investigators found that the test was able to distinguish cancer localized to the prostate from cancer that spread to other parts of the body.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Diagnostic Technologies, Sepsis |
Cytovale, a medical diagnostics company focused on advancing early detection technologies, announced that its IntelliSep test has received U.S. Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis.
Read MorePosted by Andy Lundin | Jan 11, 2023 | Dementias & Alzheimer’s |
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read MorePosted by Andy Lundin | Jan 10, 2023 | Lung Cancer |
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read More